US regulators approve first drug for nocturnal polyuria
US regulators have issued a green light for the first treatment for frequent urination at night due to overproduction of urine, a condition known as nocturnal polyuria.
Read More
Tag: nocturnal polyuria
Ferring launches nocturia drug for adults of all ages
Ferring Pharmaceuticals has launched Noqdirna in the UK, offering the only licensed treatment for the symptomatic treatment of nocturia due to nocturnal polyuria in adults of all ages.
Read More
- ErVimmune raises 17m euros in funding to develop cancer vaccine
- Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026
- Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
- Venner Shipley announces opening of new Bristol office
- AAX Biotech and Vascurie announce new neuro-oncology collaboration
